TPX2 was overexpressed in human cSCC patients, when silence of TPX2, the proliferation, migration, and invasion of cSCC cells were inhibited, while cell apoptosis was promoted through p53 signaling pathway 24. Here, TP53 is linked to skin squamous cell carcinoma.